What are validated self-report adherence scales really measuring?: A systematic review

British Journal of Clinical Pharmacology

Volumn 77, Issue 3, 2014, Pages 427-445

  Nguyen, Thi My Uyen ^a   Caze, Adam La ^a   Cottrell, Neil ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

adherence scales; adherence tools; medication adherence; questionnaires; surveys

Indexed keywords

ADHERENCE SCALES; ADHERENCE TOOLS; MEDICATION ADHERENCE; QUESTIONNAIRES; SURVEYS;

CULTURE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MEDICATION ADHERENCE; PATIENTS; REPRODUCIBILITY OF RESULTS; SELF REPORT;

EID: 84894474717     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12194     Document Type: Review

References (103)

1. World Health Organization (WHO). Adherence to Long-Term Therapies: Evidence for Action. Geneva: WHO, 2003.
2. Mardby AC, Akerlind I, Jorgensen T,. Beliefs about medicines and self-reported adherence among pharmacy clients. Patient Educ Couns 2007; 69: 158-164.
3. Fawzi W, Abdel Mohsen MY, Hashem AH, Moussa S, Coker E, Wilson KC,. Beliefs about medications predict adherence to antidepressants in older adults. Int Psychogeriatr 2012; 24: 159-169.
4. Hogan TP, Awad AG, Eastwood R,. A self-report scale predictive of drug compliance in schizophrenics-reliability and discriminative validity. Psychol Med 1983; 13: 177-183.
5. van de Steeg N, Sielk M, Pentzek M, Bakx C, Altiner A,. Drug-adherence questionnaires not valid for patients taking blood-pressure-lowering drugs in a primary health care setting. J Eval Clin Pract 2009; 15: 468-472.
6. Broekmans S, Dobbels F, Milisen K, Morlion B, Vanderschueren S,. Pharmacologic pain treatment in a multidisciplinary pain center: do patients adhere to the prescription of the physician? Clin J Pain 2010; 26: 81-86.
7. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS,. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005; 43: 521-530.
8. Lambert EV, Steyn K, Stender S, Everage N, Fourie JM, Hill M,. Cross-cultural validation of the hill-bone compliance to high blood pressure therapy scale in a South African, primary healthcare setting. Ethn Dis 2006; 16: 286-291.
9. Gehi AK, Ali S, Na B, Whooley MA,. Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the Heart and Soul Study. Arch Intern Med 2007; 167: 1798-1803.
10. Horne R, Weinman J, Hankins M,. The Beliefs about Medicines Questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999; 14: 1-24.
11. Unni EJ, Farris KB,. Unintentional non-adherence and belief in medicines in older adults. Patient Educ Couns 2011; 83: 265-268.
12. Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, Dobbels F, Fargher E, Morrison V, Lewek P, Matyjaszczyk M, Mshelia C, Clyne W, Aronson JK, Urquhart J, Team ABCP. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 2012; 73: 691-705.
13. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X,. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008; (2): CD000011.
14. Cutrona SL, Choudhry NK, Fischer MA, Servi AD, Stedman M, Liberman JN, Brennan TA, Shrank WH,. Targeting cardiovascular medication adherence interventions. J Am Pharm Assoc 2012; 52: 381-397.
15. Fenerty SD, West C, Davis SA, Kaplan SG, Feldman SR,. The effect of reminder systems on patients' adherence to treatment. Patient Prefer Adherence 2012; 6: 127-135.
16. Schroeder K, Fahey T, Ebrahim S,. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev 2004; (2): CD004804.
17. Schedlbauer A, Schroeder K, Peters TJ, Fahey T,. Interventions to improve adherence to lipid lowering medication. Cochrane Database Syst Rev 2004; (4): CD004371.
18. Eidlitz-Markus T, Zeharia A, Baum G, Mimouni M, Amir J,. Use of the urine color test to monitor compliance with isoniazid treatment of latent tuberculosis infection. Chest 2003; 123: 736-739.
19. Saberi P, Caswell N, Amodio-Groton M, Alpert P,. Pharmacy-refill measure of adherence to efavirenz can predict maintenance of HIV viral suppression. AIDS Care 2008; 20: 741-745.
20. Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P,. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care 2009; 15: 59-66.
21. van den Boogaard J, Lyimo RA, Boeree MJ, Kibiki GS, Aarnoutse RE,. Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study. Bull World Health Organ 2011; 89: 632-639.
22. Wu JR, Moser DK, Chung ML, Lennie TA,. Objectively measured, but not self-reported, medication adherence independently predicts event-free survival in patients with heart failure. J Card Fail 2008; 14: 203-210.
23. Velligan DI, Wang M, Diamond P, Glahn DC, Castillo D, Bendle S, Lam YW, Ereshefsky L, Miller AL,. Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatr Serv 2007; 58: 1187-1192.
24. Pai ALH, Drotar D, Kodish E,. Correspondence between objective and subjective reports of adherence among adolescents with acute lymphoblastic leukemia. Child Health Care 2008; 37: 225-235.
25. Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, Bamberger JD, Chesney MA, Moss A,. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000; 14: 357-366.
26. Mason BJ, Matsuyama JR, Jue SG,. Assessment of sulfonylurea adherence and metabolic control. Diabetes Educ 1995; 21: 52-57.
27. Schectman JM, Nadkarni MM, Voss JD,. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 2002; 25: 1015-1021.
28. Remington G, Kwon J, Collins A, Laporte D, Mann S, Christensen B,. The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia. Schizophr Res 2007; 90: 229-237.
29. Santschi V, Wuerzner G, Schneider MP, Bugnon O, Burnier M,. Clinical evaluation of IDAS II, a new electronic device enabling drug adherence monitoring. Eur J Clin Pharmacol 2007; 63: 1179-1184.
30. van Onzenoort HA, Neef C, Verberk WW, van Iperen HP, de Leeuw PW, van der Kuy PH,. Determining the feasibility of objective adherence measurement with blister packaging smart technology. Am J Health Syst Pharm 2012; 69: 872-879.
31. Daniels T, Goodacre L, Sutton C, Pollard K, Conway S, Peckham D,. Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers. Chest 2011; 140: 425-432.
32. Zelikovsky N, Schast AP,. Eliciting accurate reports of adherence in a clinical interview: development of the Medical Adherence Measure. Pediatr Nurs 2008; 34: 141-146.
33. Byerly MJ, Nakonezny PA, Rush AJ,. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Schizophr Res 2008; 100: 60-69.
34. Morisky DE, Ang A, Krousel-Wood M, Ward HJ,. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens 2008; 10: 348-354.
35. Wagner GJ, Rabkin JG,. Measuring medication adherence: are missed doses reported more accurately then perfect adherence? AIDS Care 2000; 12: 405-408.
36. Barfod TS, Sorensen HT, Nielsen H, Rodkjaer L, Obel N,. 'Simply forgot' is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence. HIV Med 2006; 7: 285-290.
37. Lavsa SM, Holzworth A, Ansani NT,. Selection of a validated scale for measuring medication adherence. J Am Pharm Assoc 2011; 51: 90-94.
38. Garfield S, Clifford S, Eliasson L, Barber N, Willson A,. Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review. BMC Med Res Methodol 2011; 11: 149.
39. Knobel H, Alonso J, Casado JL, Collazos J, Gonzalez J, Ruiz I, Kindelan JM, Carmona A, Juega J, Ocampo A,. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study. AIDS 2002; 16: 605-613.
40. Svarstad BL, Chewning BA, Sleath BL, Claesson C,. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns 1999; 37: 113-124.
41. Schroeder K, Fahey T, Hay AD, Montgomery A, Peters TJ,. Adherence to antihypertensive medication assessed by self-report was associated with electronic monitoring compliance. J Clin Epidemiol 2006; 59: 650-651.
42. Bell DJ, Kapitao Y, Sikwese R, van Oosterhout JJ, Lalloo DG,. Adherence to antiretroviral therapy in patients receiving free treatment from a government hospital in Blantyre, Malawi. J Acquir Immune Defic Syndr 2007; 45: 560-563.
43. Grymonpre RE, Didur CD, Montgomery PR, Sitar DS,. Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother 1998; 32: 749-754.
44. Kerr T, Hogg RS, Yip B, Tyndall MW, Montaner J, Wood E,. Validity of self-reported adherence among injection drug users. J Int Assoc Physicians AIDS Care 2008; 7: 157-159.
45. Matza LS, Park J, Coyne KS, Skinner EP, Malley KG, Wolever RQ,. Derivation and validation of the ASK-12 adherence barrier survey. Ann Pharmacother 2009; 43: 1621-1630.
46. Hahn SR, Park J, Skinner EP, Yu-Isenberg KS, Weaver MB, Crawford B, Flowers PW,. Development of the ASK-20 adherence barrier survey. Curr Med Res Opin 2008; 24: 2127-2138.
47. Godin G, Gagné C, Naccache H,. Validation of a self-reported questionnaire assessing adherence to antiretroviral medication. AIDS Patient Care STDs 2003; 17: 325-332.
48. Reynolds K, Viswanathan HN, O'Malley CD, Muntner P, Harrison TN, Cheetham TC, Hsu JW, Gold DT, Silverman S, Grauer A, Morisky DE,. Psychometric properties of the Osteoporosis-specific Morisky Medication Adherence Scale in postmenopausal women with osteoporosis newly treated with bisphosphonates. Ann Pharmacother 2012; 46: 659-670.
49. Rodriguez Martinez CE, Sossa MP, Rand CS,. Validation of a questionnaire for assessing adherence to metered-dose inhaler use in asthmatic children. Pediatr Allergy Immunol Pulmonol 2007; 20: 243-253.
50. Schuz B, Wurm S, Ziegelmann JP, Warner LM, Tesch-Romer C, Schwarzer R,. Changes in functional health, changes in medication beliefs, and medication adherence. Health Psychol 2011; 30: 31-39.
51. Kripalani S, Risser J, Gatti ME, Jacobson TA,. Development and evaluation of the Adherence to Refills and Medications Scale (ARMS) among low-literacy patients with chronic disease. Value Health 2009; 12: 118-123.
52. Kalichman SC, Amaral CM, Swetzes C, Jones M, Macy R, Kalichman MO, Cherry C,. A simple single-item rating scale to measure medication adherence: further evidence for convergent validity. J Int Assoc Physicians AIDS Care 2009; 8: 367-374.
53. Barroso PF, Schechter M, Gupta P, Bressan C, Bomfim A, Harrison LH,. Adherence to antiretroviral therapy and persistence of HIV RNA in semen. J Acquir Immune Defic Syndr 2003; 32: 435-440.
54. Mannheimer SB, Mukherjee R, Hirschhorn LR, Dougherty J, Celano SA, Ciccarone D, Graham KK, Mantell JE, Mundy LM, Eldred L, Botsko M, Finkelstein R,. The CASE adherence index: a novel method for measuring adherence to antiretroviral therapy. AIDS Care 2006; 18: 853-861.
55. Willey C, Redding C, Stafford J, Garfield F, Geletko S, Flanigan T, Melbourne K, Mitty J, Caro JJ,. Stages of change for adherence with medication regimens for chronic disease: development and validation of a measure. Clin Ther 2000; 22: 858-871.
56. Brooks CM, Richards JM, Kohler CL, Soong SJ, Martin B, Windsor RA, Bailey WC,. Assessing adherence to asthma medication and inhaler regimens: a psychometric analysis of adult self-report scales. Med Care 1994; 32: 298-307.
57. Choo PW, Rand CS, Inui TS, Lee ML, Cain E, Cordeiro-Breault M, Canning C, Platt R,. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999; 37: 846-857.
58. Chisholm MA, Lance CE, Williamson GM, Mulloy LL,. Development and validation of an immunosuppressant therapy adherence barrier instrument. Patient Educ Couns 2005; 20: 181-188.
59. Munoz-Moreno JA, Fumaz CR, Ferrer MJ, Tuldra A, Rovira T, Viladrich C, Bayes R, Burger DM, Negredo E, Clotet B,. Assessing self-reported adherence to HIV therapy by questionnaire: the SERAD (Self-Reported Adherence) Study. AIDS Res Hum Retroviruses 2007; 23: 1166-1175.
60. Greaves CJ, Hyland ME, Halpin DM, Blake S, Seamark D,. Patterns of corticosteroid medication use: non-adherence can be effective in milder asthma. Prim Care Respir J 2005; 14: 99-105.
61. de Klerk E, van der Heijde D, van der Tempel H, van der Linden S,. Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy. J Rheumatol 1999; 26: 2635-2641.
62. Kim MT, Hill MN, Bone LR, Levine DM,. Development and testing of the hill-bone compliance to high blood pressure therapy scale. Summer 2000; 15: 90-96.
63. Lewis SJ, Abell N,. Development and evaluation of the Adherence Attitude Inventory. Res Soc Work Pract 2002; 12: 107-123.
64. Ogedegbe G, Mancuso CA, Allegrante JP, Charlson ME,. Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients. J Clin Epidemiol 2003; 56: 520-529.
65. Risser J, Jacobson TA, Kripalani S,. Development and psychometric evaluation of the self-efficacy for appropriate medication use scale (SEAMS) in low-literacy patients with chronic disease. J Nurs Meas 2007; 15: 203-219.
66. Unni EJ, Farris KB,. Development of a new scale to measure self-reported medication nonadherence. Res Social Adm Pharm 2009. [Epub ahead of print].
67. George J, Mackinnon A, Kong DC, Stewart K,. Development and validation of the Beliefs and Behaviour Questionnaire (BBQ). Patient Educ Couns 2006; 64: 50-60.
68. Dolder CR, Lacro JP, Warren KA, Golshan S, Perkins DO, Jeste DV,. Brief evaluation of medication influences and beliefs: development and testing of a brief scale for medication adherence. J Clin Psychopharmacol 2004; 24: 404-409.
69. Wetzels G, Nelemans P, van Wijk B, Broers N, Schouten J, Prins M,. Determinants of poor adherence in hypertensive patients: development and validation of the 'Maastricht Utrecht Adherence in Hypertension (MUAH)-questionnaire'. Patient Educ Counsel 2006; 64: 151-158.
70. Thompson K, Kulkarni J, Sergejew AA,. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 2000; 42: 241-247.
71. Jonsdottir H, Opjordsmoen S, Birkenaes AB, Engh JA, Ringen PA, Vaskinn A, Aamo TO, Friis S, Andreassen OA,. Medication adherence in outpatients with severe mental disorders: relation between self-reports and serum level. J Clin Psychopharmacol 2010; 30: 169-175.
72. Fodor GJ, Kotrec M, Bacskai K, Dorner T, Lietava J, Sonkodi S, Rieder A, Turton P,. Is interview a reliable method to verify the compliance with antihypertensive therapy? An international central-European study. J Hypertens 2005; 23: 1261-1266.
73. Morisky DE, Green LW, Levine DM,. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67-74.
74. Thompson IR, Bidgood P, Petroczi A, Denholm-Price JC, Fielder MD, EuResist Network Study G,. An alternative methodology for the prediction of adherence to anti HIV treatment. AIDS Res Ther 2009; 6: 9-14.
75. de Klerk E, van der Heijde D, Landewe R, van der Tempel H, van der Linden S,. The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study. J Rheumatol 2003; 30: 2469-2475.
76. Shalansky SJ, Levy AR, Ignaszewski AP,. Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacother 2004; 38: 1363-1368.
77. Toll BA, McKee SA, Martin DJ, Jatlow P, O'Malley SS,. Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit. Nicotine Tob Res 2007; 9: 597-605.
78. Elm JJ, Kamp C, Tilley BC, Guimaraes P, Fraser D, Deppen P, Brocht A, Weaver C, Bennett S, Investigators NN-P, Coordinators. Self-reported adherence versus pill count in Parkinson's disease: the NET-PD experience. Mov Disord 2007; 22: 822-827.
79. Fernandez S, Chaplin W, Schoenthaler AM, Ogedegbe G,. Revision and validation of the medication adherence self-efficacy scale (MASES) in hypertensive African Americans. J Behav Med 2008; 31: 453-462.
80. Clayton CD, Veach J, Macfadden W, Haskins J, Docherty JP, Lindenmayer JP,. Assessment of clinician awareness of nonadherence using a new structured rating scale. J Psychiatr Pract 2010; 16: 164-169.
81. Gardner EM, Hullsiek KH, Telzak EE, Sharma S, Peng G, Burman WJ, MacArthur RD, Chesney M, Friedland G, Mannheimer SB,. Antiretroviral medication adherence and class- specific resistance in a large prospective clinical trial. AIDS 2010; 24: 395-403.
82. Addison CC, Jenkins BW, Sarpong D, Wilson G, Champion C, Sims J, White MS,. Relationship between medication use and cardiovascular disease health outcomes in the Jackson Heart Study. Int J Environ Res Public Health 2011; 8: 2505-2515.
83. Krousel-Wood MA, Muntner P, Islam T, Morisky DE, Webber LS,. Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults. Med Clin North Am 2009; 93: 753-769.
84. Gearing RE, Townsend L, MacKenzie M, Charach A,. Reconceptualizing medication adherence: six phases of dynamic adherence. Harv Rev Psychiatry 2011; 19: 177-189.
85. Horne R, Weinman J,. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health 2002; 17: 17-32.
86. Ross S, Walker A, MacLeod MJ,. Patient compliance in hypertension: role of illness perceptions and treatment beliefs. J Hum Hypertens 2004; 18: 607-613.
87. Berglund E, Lytsy P, Westerling R,. Adherence to and beliefs in lipid-lowering medical treatments: a structural equation modeling approach including the necessity-concern framework. Patient Educ Couns 2013; 91: 105-112.
88. Alhalaiqa F, Deane KH, Nawafleh AH, Clark A, Gray R,. Adherence therapy for medication non-compliant patients with hypertension: a randomised controlled trial. J Hum Hypertens 2012; 26: 117-126.
89. Petrie KJ, Perry K, Broadbent E, Weinman J,. A text message programme designed to modify patients' illness and treatment beliefs improves self-reported adherence to asthma preventer medication. Br J Health Psychol 2012; 17: 74-84.
90. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, Wu AW,. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 2000; 12: 255-266.
91. Dobbels F, Berben L, De Geest S, Drent G, Lennerling A, Whittaker C, Kugler C,. Transplant360 Task F. The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: a systematic review. Transplantation 2010; 90: 205-219.
92. Lapshin O,. Assessing medication adherence in clinical practice. Bridg East West Psychiatry 2006; 4: 42-45.
93. Kleeberger CA, Phair JP, Strathdee SA, Detels R, Kingsley L, Jacobson LP,. Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 2001; 26: 82-92.
94. Zeller A, Ramseier E, Teagtmeyer A, Battegay E,. Patients' self-reported adherence to cardiovascular medication using electronic monitors as comparators. Hypertens Res 2008; 31: 2037-2043.
95. Matza LS, Yu-Isenberg KS, Coyne KS, Park J, Wakefield J, Skinner EP, Wolever RQ,. Further testing of the reliability and validity of the ASK-20 adherence barrier questionnaire in a medical center outpatient population. Curr Med Res Opin 2008; 24: 3197-3206.
96. Erickson SR, Coombs JH, Kirking DM, Azimi AR,. Compliance from self-reported versus pharmacy claims data with metered-dose inhalers. Ann Pharmacother 2001; 35: 997-1003.
97. Wang Y, Kong MC, Ko Y,. Psychometric properties of the 8-item Morisky Medication Adherence Scale in patients taking warfarin. Thromb Haemost 2012; 108: 1-7.
98. Hill-Briggs F, Gary TL, Bone LR, Hill MN, Levine DM, Brancati FL,. Medication adherence and diabetes control in urban African Americans with type 2 diabetes. Health Psychol 2005; 24: 349-357.
99. Vik SA, Maxwell CJ, Hogan DB, Patten SB, Johnson JA, Romonko-Slack L,. Assessing medication adherence among older persons in community settings. Can J Clin Pharmacol 2005; 12: 152-164.
100. Wang Y, Lee J, Tang WE, Toh MP, Ko Y,. Validity and reliability of a self-reported measure of medication adherence in patients with Type 2 diabetes mellitus in Singapore. Diabet Med 2012; 29: 338-344.
101. Brown C, Battista DR, Bruehlman R, Sereika SS, Thase ME, Dunbar-Jacob J,. Beliefs about antidepressant medications in primary care patients: relationship to self-reported adherence. Med Care 2005; 43: 1203-1207.
102. Gatti ME, Jacobson KL, Gazmararian JA, Schmotzer B, Kripalani S,. Relationships between beliefs about medications and adherence. Am J Health Sys Pharm 2009; 66: 657-664.
103. Fialko L, Garety PA, Kuipers E, Dunn G, Bebbington PE, Fowler D, Freeman D,. A large-scale validation study of the Medication Adherence Rating Scale (MARS). Schizophr Res 2008; 100: 53-59